Brief: Actinium Pharmaceuticals Announces Reverse Stock Split
10/08/2020 19:38
Aug 10 (Reuters) - Actinium Pharmaceuticals Inc ATNM.A :
* ACTINIUM PHARMACEUTICALS, INC. ANNOUNCES REVERSE STOCK
SPLIT
* ACTINIUM PHARMACEUTICALS - BOARD APPROVED 1-FOR-30 REVERSE
SPLIT
OF COMMON STOCK THAT WILL BECOME EFFECTIVE AFTER TRADING CLOSES
ON AUGUST 10
* ACTINIUM PHARMACEUTICALS - TRADING OF CO'S COMMON STOCK
WILL
BEGIN ON SPLIT-ADJUSTED BASIS WHEN MARKETS OPEN ON AUG 11, 2020
Source text for Eikon: urn:newsml:reuters.com:*:nPn66q3fa
Further company coverage: ATNM.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Actinium Pharmaceuticals
See all newsBrief: Actinium Pharmaceuticals - Receives Two Canadian Patent Allowances For Actimab-A And Iomab-Act Programs
Brief: ctinium’s Atnm-400 Shows Strong Efficacy in TNBC, Beats Therapy Resistance at SABCS
Brief: Actinium Pharmaceuticals Says ATNM-400 Shows Superior Efficacy To Xtandi In Prostate Cancer
Brief: Actinium Pharmaceuticals Announces ATNM-400 A Novel Non-PSMA Targeting First In Class Prostate Cancer Radiotherapy Leveraging Actinium-225
Brief: Actinium Pharmaceuticals Announces Supply Agreement With Eckert & Ziegler For AC-225 Radioisotope To Support Comprehensive Development Activities